The global Biopharmaceuticals Market connected with therapeutic biologics

Biopharmaceuticals Market



Market Overview:

The biopharmaceuticals market comprises medicines produced using biotechnology methods like genetic engineering and includes vaccines, blood components, recombinant therapeutic proteins/antibodies, and monoclonal antibodies. Biopharmaceuticals are often used for treating serious medical conditions like cancer, autoimmune diseases, and other chronic disorders. These drugs provide targeted treatment options and have lesser side effects than traditional small-molecule drugs. The market is witnessing high demand due to increasing prevalence of chronic diseases and growing geriatric population globally.

Market key trends:
One of the key trends gaining traction in The Biopharmaceuticals Market Demand is the increasing adoption of biosimilars. Biosimilars are quasi-generic versions of original biologics and provide more affordable treatment options when the patents of biologics expire. Regulatory agencies in various regions are also approving biosimilars to enhance competition and reduce healthcare costs. For instance, the U.S. FDA had approved over 50 biosimilars as of January 2023. The patents expiration of major biologics is also expected to increase biosimilars market share in the forecast period. This trend is expected to drive the overall growth of the biopharmaceuticals market.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is relatively low in the biopharmaceuticals market due to huge R&D costs involved in developing new biopharmaceutical drugs and stringent regulatory requirements.

Bargaining power of buyers: The bargaining power of buyers is moderate as biopharmaceutical drugs are usually developed for specific therapeutic areas with limited substitutes. However, pricing pressure exists from governing bodies and insurance companies.

Bargaining power of suppliers: The bargaining power of suppliers is moderate given the specialized expertise required. However, presence of alternative material and device suppliers keeps their bargaining power in check.

Threat of new substitutes: The threat of new substitutes is moderate as new drug delivery technologies and therapeutics occasionally challenge existing biopharmaceutical drugs.

Competitive rivalry: The competitive rivalry is high among existing players given their focus on pipeline development and product launches to gain market share.

Key Takeaways

The global biopharmaceuticals market is expected to witness high growth, exhibiting CAGR of 7.4% over the forecast period 2023-2030, due to increasing prevalence of chronic diseases and rising demand for monoclonal antibodies and recombinant proteins.

The North America region currently dominates the biopharmaceuticals market owing to presence of major players and supportive regulatory environment. However, Asia Pacific region is expected to grow at the fastest pace during the forecast period due to rising healthcare expenditure, increasing disposable incomes and growing incidences of lifestyle diseases in countries like China and India.

Key players operating in the biopharmaceuticals market are Amgen Inc., Abbvie Inc., GlaxoSmithKline PLC, Pfizer Inc., Novo Nordisk AS, Novartis AG, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche Ltd., among others. These players are focused on expanding their product portfolios through acquisitions and partnerships with biotech companies to strengthen their market position.

Read More:

https://www.dailyprbulletin.com/biopharmaceuticals-market-share-growth-and-demand/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more